ClinicalThought

Share

Program Content

Activities

  • Sequencing FL Therapy
    How I Sequence Therapy for Patients With Follicular Lymphoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 01, 2021

    Expires: October 31, 2022

  • Sequencing BTKi in MZL
    Sequencing BTK Inhibitors in Treatment of Marginal Zone Lymphomas
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 02, 2021

    Expires: November 01, 2022

  • Treating MCL
    How I Treat Patients With Mantle Cell Lymphoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 12, 2021

    Expires: November 11, 2022

  • Treating DLBCL
    How I Sequence Treatment for Patients With Diffuse Large B-Cell Lymphoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 01, 2021

    Expires: November 30, 2022

  • Treating EBV+ PTLD
    How I Treat Patients With EBV-Associated Posttransplant Lymphoproliferative Disease
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2021

    Expires: December 05, 2022

Faculty

cover img faculity

Brad S. Kahl, MD

Skoronski Chair of Lymphoma Research
Associate Director for Clinical Research
UW Carbone Cancer Center
University of Wisconsin School of Public Health
Madison, Wisconsin

cover img faculity

John P. Leonard, MD

Chief, Lymphoma/Myeloma Service
Division of Hematology and Oncology
Weill Medical College of Cornell University
New York Presbyterian Hospital
New York Weill Cornell Center
New York, New York

cover img faculity

Julie M. Vose, MD

Neumann M. and Mildred E. Harris Professor
Chief
, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

Atara Biotherapeutics

Bayer Healthcare Pharma

BeiGene, Ltd.

Epizyme

Genentech, a member of the Roche Group

Genmab US

Incyte Corporation

Karyopharm Therapeutics

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc